Infantile autism

disorder

SNOMED 408857007CUI C0004352

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Quetiapine fumarate

substance

Venlafaxine hydrochloride

substance

Venlafaxine

substance

Risperidone

substance

Quetiapine

substance

Fenfluramine hydrochloride

substance

Fenfluramine

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Electroencephalogram abnormal

Frequent (30-79%)HP:0002353

Increased serum serotonin

Frequent (30-79%)HP:0003144

Seizures

Frequent (30-79%)HP:0001250

Abnormal nonverbal communicative behavior

HP:0000758

Autism

HP:0000717

Impaired ability to form peer relationships

HP:0000728

Inflexible adherence to routines

HP:0000732

Lack of spontaneous play

HP:0000721

Low intelligence

HP:0001249

Restricted behaviour

HP:0000723

Speech delay

HP:0000750

Stimming

HP:0000733

Related Conditions

Active infantile autism(child)

Residual infantile autism(child)

Mental disorder in infancy(parent)

Pervasive developmental disorder(parent)

Quick Facts

SNOMED CT: 408857007
UMLS CUI: C0004352
Fully Specified Name: Infantile autism (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 12
Known Treatments: 7

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.